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Purpose of the study
To assess estimated cardiovascular risk in a population of
adult HIV-infected patients.
Methods
This is an ongoing, prospective, longitudinal, multicenter
cohort study of estimated cardiovascular risk (eCVR).
After obtaining informed consent, demographic charac-
teristics, metabolic parameters, and clinical status, includ-
ing CVR factors, of patients (pts) enrolled from February
to August 2006 at 12 Spanish sites were recorded in a cen-
tral database using an Access data set. eCVR was evaluated
by the Framingham equation. For analysis purposes pts
were grouped into: 1) low eCVR (< 10% at 10 years); or 2)
moderate/high eCVR (> 10%). Descriptive statistics were
expressed as median (interquartile range) for quantitative
variables and as percentages for qualitative variables.
Logistic regression was used to identify the factors that
might account for a higher eCVR. Baseline data are pre-
sented.
Summary of results
807 pts were included: 73% men, median age 41 (18–83)
years, 42% drug users, 26% AIDS, CD4 465/uL, 51%
undetectable viral load, 74% taking HAART (51% PI, 49%
NNRTI regimens), 64% smokers, 10% hypertension, 5%
diabetes, 3.5% coronary or cardiovascular disease (CVD).
81% pts had < 10 eCVR (Grp. 1) and 19% ≥10 eCVR (Grp.
2). Grp. 2 pts were more frequently men, older, non-drug
users, smokers, diabetics, hypertensive, had CVD, lipid
disturbances, greater waist circumference, greater BMI,
undetectable viral load, and used more stavudine and
indinavir. On univariate analysis, male sex (OR 8.51), cor-
onary disease (5.77), CVD (3.87), diabetes (3.87), hyper-
tension (3.66), smoking (1.96), age (1.16), lipid
alterations (total cholesterol, HDL, LDL, Tryglicerides, no-
HDL and TC/HDL, 1.02 to 1.52), waist circumference
(1.04), and BMI (1.04) were associated with increased
eCVR, while detectable viral load was associated with a
low eCVR (0.47). First or current antiretroviral drugs were
not associated with increased eCVR. On multivariate anal-
ysis, male sex (OR 19.96), age (25.08), smoking (24.12),
hypertension (5.41), and total cholesterol (1.04)
remained significantly associated with increased eCVR
while detectable viral load (0.38) and HDL (0.94)
remained significantly associated with a low eCVR.
Conclusion
Traditional cardiovascular risk factors are associated with
increased eCVR in our HIV population, and seem to have
a stronger role than HAART and HIV infection. Lower
eCVR in pts with detectable viral loads is probably related
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to younger age, lower waist circumference and systolic
blood pressure, and a better lipid profile. Pts with higher
eCVR may benefit from lipid-friendly ARV therapy, but
interventions on life habits are crucial.Page 2 of 2
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